Form 4: Ingredion Executive VP and CFO, James D. Gray, Executes Stock Option and Sells Shares

Ingredion's Executive VP and CFO, James D. Gray, exercised stock options and sold shares on November 29, 2024, resulting in a net decrease in his direct holdings.

Summary

• On November 29, 2024, James D. Gray, Executive VP and CFO of Ingredion Inc., engaged in multiple transactions involving the company's common stock.
• Mr. Gray exercised stock options to acquire 4,807 shares at $99.96, 12,090 shares at $118.97, 18,352 shares at $130.30, and 19,620 shares at $91.85.
• Concurrently, he sold 4,807 shares at an average price of $146.693, 12,090 shares at an average price of $146.766, 18,352 shares at an average price of $146.782, and 19,620 shares at an average price of $146.758.
• These transactions resulted in a decrease in Mr. Gray's directly held common stock from 30,088 to 12,795.1224 shares, after accounting for restricted stock units acquired through deemed dividend reinvestment.
• The stock options exercised were granted at various times and vested in three equal annual installments.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction by an executive, with no clear positive or negative implications for the company's performance. It is a neutral event.

Negatives

• The sale of shares by the CFO could be interpreted negatively by some investors, although it is a common practice after exercising stock options.

Risks

• Executive stock sales can sometimes be perceived as a lack of confidence in the company's future performance, although this is not always the case.
• The market may react to these transactions, potentially causing short-term volatility in the stock price.

Industry Context

This type of transaction is common for executives who receive stock options as part of their compensation. It is a routine part of executive compensation and does not necessarily indicate a change in the company's outlook.

Comparison to Industry Standards

• Executive stock option exercises and sales are a standard practice across publicly traded companies, including competitors like ADM, Tate & Lyle, and Cargill.
• The timing and volume of these transactions are often dictated by vesting schedules and personal financial planning, rather than company performance.
• Similar filings can be observed for executives at comparable companies, reflecting the common use of equity-based compensation.

Stakeholder Impact

• The transactions may have a minor impact on the stock price in the short term, but are unlikely to have a significant long-term effect on shareholders.
• Employees may view the transactions as a normal part of executive compensation.

Key Dates

Keywords

Ingredion, Executive Stock Options, Form 4, Insider Trading, Stock Sale, James D. Gray, CFO, Equity Securities